E72Q (p.Glu72Gln) variant of NFKBIA (NF-kappa-B inhibitor alpha)
E72Q (p.Glu72Gln) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
E72Q (p.Glu72Gln) variant details
- p.Glu72Gln
- NCI-TCGA Cosmic COSV9939
- cosmic curated COSV99394
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.48
- MetaSVM -0.27
- SIFT 0.12
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available